MARAVAI LIFESCIENCES HLDGS-A (MRVI) Stock Analyst Earnings Estimates
NASDAQ:MRVI - Nasdaq - US56600D1072 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 799.2M 181.31% | 883M 10.49% | 288.945M -67.28% | 265.31M -8.18% | 270.42M 1.93% | 302.25M 11.77% | 339.51M 12.33% | 384.35M 13.21% | 468.81M 21.97% | 641.36M 36.81% | 785.67M 22.50% | 942.8M 20.00% | |
| EBITDA YoY % growth | 568.1M 348.38% | 606.1M 6.69% | 15.072M -97.51% | 45.784M 203.77% | 49.907M 9.01% | 64.891M 30.02% | 80.274M 23.71% | 101.8M 26.82% | 109.45M 7.51% | N/A | N/A | N/A | |
| EBIT YoY % growth | 543.4M 438.55% | 574.2M 5.67% | -25.182M -104.39% | -1.736M 93.10% | 1.097M 163.18% | 20.47M 1,766.00% | 98.94M 383.34% | 126.48M 27.84% | N/A | N/A | N/A | N/A | |
| Operating Margin | 67.99% | 65.03% | -8.72% | -0.65% | 0.41% | 6.77% | 29.14% | 32.91% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 1.59 330.61% | 1.80 13.21% | 0.03 -98.33% | -0.08 -369.72% | -0.07 17.65% | 0.00 94.70% | 0.02 678.03% | 0.08 283.50% | -0.02 -126.08% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 -508.00% | -0.02 -9.85% | -0.02 | -0.01 29.37% | -0.01 72.73% | -0.02 7.15% | -0.01 40.90% | 0.00 100.00% | 0.00 100.00% |
| Revenue Q2Q % growth | 58.491M -21.11% | 64.9M 1.12% | 68.043M -7.30% | 68.727M 5.41% | 70.407M 20.37% | 71.084M 9.53% | 73.18M 7.55% | 75.393M 9.70% | 77.372M 9.89% |
| EBITDA Q2Q % growth | 6.799M -82.82% | 9.795M 216.36% | 12.246M -15.92% | 12.448M -41.11% | 13.336M 96.15% | 12.954M 32.25% | 16.544M 35.10% | 18.972M 52.41% | 18.692M 40.16% |
| EBIT Q2Q % growth | -3.621M -429.37% | -1.8M 91.03% | -1.226M 87.12% | 679.096K 104.56% | 3.264M 190.14% | 3.504M 294.71% | 7.002M 671.11% | 9.44M 1,290.08% | 9.139M 179.99% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.02 -100.00% | -0.01 | -0.01 | -154.98% |
| Q2 2024 Q2Q % growth | 0.00 | 0.00 | 0.00 | -100.00% |
| Q1 2024 Q2Q % growth | -0.02 -166.67% | -0.03 | 0.01 | 22.99% |
| Q4 2023 Q2Q % growth | 0.01 -97.14% | -0.01 | 0.02 | 182.94% |
| Q3 2023 Q2Q % growth | -0.01 -102.70% | 0.01 | -0.02 | -254.15% |
| Q2 2023 Q2Q % growth | 0.00 -100.00% | 0.01 | -0.01 | -100.00% |
| Q1 2023 Q2Q % growth | 0.03 -94.44% | 0.04 | -0.01 | -18.86% |
| Q4 2022 Q2Q % growth | 0.35 -22.22% | 0.35 | 0.00 | 0.38% |
| Q3 2022 Q2Q % growth | 0.37 -15.91% | 0.34 | 0.03 | 9.99% |
| Q2 2022 Q2Q % growth | 0.54 22.73% | 0.46 | 0.08 | 16.50% |
| Q1 2022 Q2Q % growth | 0.54 107.69% | 0.45 | 0.09 | 20.63% |
| Q4 2021 Q2Q % growth | 0.45 246.15% | 0.39 | 0.06 | 14.76% |
| Q3 2021 Q2Q % growth | 0.44 | 0.36 | 0.08 | 22.47% |
| Q2 2021 Q2Q % growth | 0.44 | 0.32 | 0.12 | 36.25% |
| Q1 2021 Q2Q % growth | 0.26 | 0.21 | 0.05 | 24.10% |
| Q4 2020 Q2Q % growth | 0.13 | 0.11 | 0.02 | 17.90% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 65.2M -2.49% | 68.906M | -3.706M | -5.38% |
| Q2 2024 Q2Q % growth | 73.4M 6.51% | 73.067M | 333K | 0.46% |
| Q1 2024 Q2Q % growth | 64.179M -18.79% | 61.759M | 2.42M | 3.92% |
| Q4 2023 Q2Q % growth | 74.141M -63.78% | 65.667M | 8.474M | 12.90% |
| Q3 2023 Q2Q % growth | 66.865M -65.05% | 77.034M | -10.169M | -13.20% |
| Q2 2023 Q2Q % growth | 68.914M -71.61% | 72.548M | -3.634M | -5.01% |
| Q1 2023 Q2Q % growth | 79.025M -67.65% | 81.315M | -2.29M | -2.82% |
| Q4 2022 Q2Q % growth | 204.7M -10.38% | 209.03M | -4.33M | -2.07% |
| Q3 2022 Q2Q % growth | 191.3M -6.59% | 199.01M | -7.71M | -3.87% |
| Q2 2022 Q2Q % growth | 242.7M 11.43% | 237.91M | 4.79M | 2.01% |
| Q1 2022 Q2Q % growth | 244.3M 64.84% | 236.94M | 7.36M | 3.11% |
| Q4 2021 Q2Q % growth | 228.4M 132.11% | 212.25M | 16.15M | 7.61% |
| Q3 2021 Q2Q % growth | 204.8M 10.26% | 205.53M | -730K | -0.36% |
| Q2 2021 Q2Q % growth | 217.8M | 198.71M | 19.09M | 9.61% |
| Q1 2021 Q2Q % growth | 148.2M | 141.26M | 6.94M | 4.91% |
| Q4 2020 Q2Q % growth | 98.4M 173.33% | 90.804M | 7.596M | 8.37% |
| Q3 2020 Q2Q % growth | 185.745M 73.30% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.45% | -786.11% | 3.42% | -139.81% |
| Revenue | 1.23% | -19.58% | 0.13% | -5.6% |